Markets

AtriCure (ATRC) in Focus: Stock Tumbles 10.2%

A generic image of a pen and on top of a chart.
Credit: Shutterstock photo

AtriCure, Inc. ( ATRC ) saw a big move last session, as the company's shares fell by over 10% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for ATRC as the stock actually increased nearly 14% from Sep 4, 2015 till Sep 20, before it plunged over 12% in the last two trading sessions.

The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks (0 increases, 0 decreases), and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

ATRC currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.

A better-ranked stock in the Medical Products industry is NuVasive ( NUVA ), which currently carries a Zacks Rank #1 (Strong Buy).

Is ATRC going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ATRICURE INC (ATRC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ATRC

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More